Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Awada

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Leukemia|May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysisHussein Awada, Arda Durmaz, Tariq Kewan, et al.
Stem Cell Research & Therapy|November 28, 2019
A comparison of BMP2 delivery by coacervate and gene therapy for promoting human muscle-derived stem cell-mediated articular cartilage repairXueqin Gao, Haizi Cheng, Hassan Awada, et al.
Haematologica|May 7, 2026
Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drivesHussein Awada, Arda Durmaz, Luca Guarnera, et al.
Blood Cells, Molecules & Diseases|December 20, 2020
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuriaCarmelo Gurnari, Amy C Graham, Alexey Efanov, et al.
Blood|March 10, 2021
Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesCarmelo Gurnari, Simona Pagliuca, Lisa Durkin, et al.
Leukemia & Lymphoma|January 9, 2019
<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomesNour Abuhadra, Sudipto Mukherjee, Karam Al-Issa, et al.
Leukemia|January 23, 2021
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal HemoglobinuriaCarmelo Gurnari, Simona Pagliuca, Bhumika J Patel, et al.
Leukemia|November 3, 2023
ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasmsHassan Awada, Manasa Bhatta, Han Yu, et al.
Leukemia|April 29, 2024
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disordersHussein Awada, Carmelo Gurnari, Valeria Visconte, et al.
British Journal of Haematology|November 19, 2019
Extended experience with a non-cytotoxic DNMT1-targeting regimen of decitabine to treat myeloid malignanciesHassan Awada, Reda Z Mahfouz, Ashwin Kishtagari, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Leukemia|May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysisHussein Awada, Arda Durmaz, Tariq Kewan, et al.
Stem Cell Research & Therapy|November 28, 2019
A comparison of BMP2 delivery by coacervate and gene therapy for promoting human muscle-derived stem cell-mediated articular cartilage repairXueqin Gao, Haizi Cheng, Hassan Awada, et al.
Haematologica|May 7, 2026
Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drivesHussein Awada, Arda Durmaz, Luca Guarnera, et al.
Blood Cells, Molecules & Diseases|December 20, 2020
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuriaCarmelo Gurnari, Amy C Graham, Alexey Efanov, et al.
Blood|March 10, 2021
Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesCarmelo Gurnari, Simona Pagliuca, Lisa Durkin, et al.
Leukemia & Lymphoma|January 9, 2019
<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomesNour Abuhadra, Sudipto Mukherjee, Karam Al-Issa, et al.
Leukemia|January 23, 2021
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal HemoglobinuriaCarmelo Gurnari, Simona Pagliuca, Bhumika J Patel, et al.
Leukemia|November 3, 2023
ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasmsHassan Awada, Manasa Bhatta, Han Yu, et al.
Leukemia|April 29, 2024
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disordersHussein Awada, Carmelo Gurnari, Valeria Visconte, et al.
British Journal of Haematology|November 19, 2019
Extended experience with a non-cytotoxic DNMT1-targeting regimen of decitabine to treat myeloid malignanciesHassan Awada, Reda Z Mahfouz, Ashwin Kishtagari, et al.
Pageof 6